Japan · Delayed Price · Currency is JPY SanBio Company Statistics
Total Valuation
SanBio Company has a market cap or net worth of JPY 78.14 billion. The enterprise value is 66.51 billion.
| Market Cap | 78.14B |
| Enterprise Value | 66.51B |
Important Dates
The last earnings date was Monday, September 14, 2026.
| Earnings Date | Sep 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SanBio Company has 78.06 million shares outstanding. The number of shares has increased by 8.09% in one year.
| Current Share Class | 78.06M |
| Shares Outstanding | 78.06M |
| Shares Change (YoY) | +8.09% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 24.91% |
| Owned by Institutions (%) | 3.25% |
| Float | 58.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.66 |
| P/TBV Ratio | 6.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 39.47, with a Debt / Equity ratio of 0.10.
| Current Ratio | 39.47 |
| Quick Ratio | 37.60 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.28 |
| Interest Coverage | -105.97 |
Financial Efficiency
Return on equity (ROE) is -55.86% and return on invested capital (ROIC) is -30.77%.
| Return on Equity (ROE) | -55.86% |
| Return on Assets (ROA) | -28.28% |
| Return on Invested Capital (ROIC) | -30.77% |
| Return on Capital Employed (ROCE) | -28.67% |
| Weighted Average Cost of Capital (WACC) | 5.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -110.18M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SanBio Company has paid 97.00 million in taxes.
| Income Tax | 97.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.04% in the last 52 weeks. The beta is 0.29, so SanBio Company's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -70.04% |
| 50-Day Moving Average | 960.64 |
| 200-Day Moving Average | 1,512.73 |
| Relative Strength Index (RSI) | 57.17 |
| Average Volume (20 Days) | 773,195 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.82B |
| Pretax Income | -3.54B |
| Net Income | -3.64B |
| EBITDA | -3.78B |
| EBIT | -3.82B |
| Earnings Per Share (EPS) | -47.70 |
Balance Sheet
The company has 12.75 billion in cash and 1.13 billion in debt, with a net cash position of 11.62 billion or 148.90 per share.
| Cash & Cash Equivalents | 12.75B |
| Total Debt | 1.13B |
| Net Cash | 11.62B |
| Net Cash Per Share | 148.90 |
| Equity (Book Value) | 11.73B |
| Book Value Per Share | 150.21 |
| Working Capital | 13.04B |
Cash Flow
In the last 12 months, operating cash flow was -3.84 billion and capital expenditures -138.00 million, giving a free cash flow of -3.98 billion.
| Operating Cash Flow | -3.84B |
| Capital Expenditures | -138.00M |
| Depreciation & Amortization | 32.00M |
| Net Borrowing | -263.00M |
| Free Cash Flow | -3.98B |
| FCF Per Share | -51.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SanBio Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.09% |
| Shareholder Yield | -8.09% |
| Earnings Yield | -4.65% |
| FCF Yield | -5.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for SanBio Company is 1,560.00, which is 55.69% higher than the current price. The consensus rating is "Hold".
| Price Target | 1,560.00 |
| Price Target Difference | 55.69% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |